Quarterly Result14 Aug 2026, 05:24 pm
Gennex Laboratories Declares Unaudited Q1 FY27 Results
AI Summary
Gennex Laboratories Ltd announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these financial statements, along with the limited review reports from the statutory auditor. The company operates in the 'Bulk Drugs, Bioteck Products and Intermediates' segment. The results were prepared in accordance with Indian Accounting Standards (Ind-AS).
Key Highlights
- Board approved unaudited standalone and consolidated financial statements.
- Financial results for the quarter ended June 30, 2026, were declared.
- Limited review reports from statutory auditors were approved.
- Company operates in the 'Bulk Drugs, Bioteck Products and Intermediates' segment.
- Results prepared as per Ind-AS standards.
Price Impact
More from GENNEX